Both ZEB1 and β-Catenin have been reported as mediators of mesenchymal transition in other tumor types.24,32 To examine their role in mesenchymal transition in GBM, the subcellular localization of both transcription factors was examined using immunofluorescence staining. This evidence concerns the gene ZEB1 and glioblastoma.